Micropulse vs continuous‐wave cyclophotocoagulation
Change in visual acuity (logMAR) ‐ 12 months (negative is better) · adults with refractory glaucoma
1 finding from 1 review
- no estimate extracted1 study · 48 participantsGRADE not reported
Findings
What do systematic reviews say?
14 questions · 14 findings · 2 reviews · Eyes and Vision · Headline outcomes only
No studies found 2 · 14.3%GRADE not reported 5 · 35.7%Very low 5 · 35.7%Low 2 · 14.3%Moderate 0 · 0%High 0 · 0%
Micropulse vs continuous‐wave cyclophotocoagulation
Mean change in the mean deviation in study eyes change from baseline 12 months postintervention · adults with refractory glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Micropulse vs continuous‐wave cyclophotocoagulation
Mean number of antiglaucoma medications at 1‐year · adults with refractory glaucoma
1 finding from 1 review
- no estimate extracted1 study · 46 participantsGRADE not reported
Micropulse vs continuous‐wave cyclophotocoagulation
Adverse events 12 months postintervention · adults with refractory glaucoma
1 finding from 1 review
- no estimate extracted1 study · 46 participantsGRADE not reported
Micropulse vs continuous‐wave cyclophotocoagulation
Mean change in quality of life scores 12 months postintervention · adults with refractory glaucoma
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Micropulse vs continuous‐wave cyclophotocoagulation
Pain control · adults with refractory glaucoma
1 finding from 1 review
- no estimate extracted1 study · 44 participantsGRADE not reported
Micropulse vs continuous‐wave cyclophotocoagulation
Mean change in IOP measured in mmHg 12 months postintervention · adults with refractory glaucoma
1 finding from 1 review
- no estimate extracted1 study · 48 participantsGRADE not reported
IPL (with/without MGX) vs no treatment/sham
Dry eye symptoms, measured using the OSDI score (ranging from 0 to 100 units, with a reduction in scores indicating clinical improvement) at 1‐month (with actual · people with meibomian gland dysfunction
It is very uncertain whether IPL (with/without MGX) changes dry eye symptoms, measured using the SPEED score at 3 months of compared with sham or no treatment (with/without MGX) (very low certainty).
1 finding from 1 review
- Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction 2020 · Cochrane Headline outcomes onlyMD 0Studies not reportedVery low
IPL (with/without MGX) vs no treatment/sham
Incidence of adverse events at 3 months of · people with meibomian gland dysfunction
1 finding from 1 review
- Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction 2020 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedVery low
IPL (with/without MGX) vs no treatment/sham
Clinical signs—TBUT at 1 month (seconds) · people with meibomian gland dysfunction
IPL (with/without MGX) showed no clear difference in sodium fluorescein TBUT, measured in seconds, at 3 months of compared with sham or no treatment (with/without MGX) (low certainty).
1 finding from 1 review
- Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction 2020 · Cochrane Headline outcomes onlyMD 2.02Studies not reportedLow
IPL (with/without MGX) vs no treatment/sham
NIBUT, measured in seconds, at 3 months of · people with meibomian gland dysfunction
It is very uncertain whether IPL (with/without MGX) changes NIBUT, measured in seconds, at 3 months of compared with sham or no treatment (with/without MGX) (very low certainty).
1 finding from 1 review
- Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction 2020 · Cochrane Headline outcomes onlyMD 5.5Studies not reportedVery low
IPL (with/without MGX) vs no treatment/sham
Tear osmolarity, measured in mOsmol/L, at 3 months of · people with meibomian gland dysfunction
IPL (with/without MGX) showed no clear difference in tear osmolarity, measured in mOsmol/L, at 3 months of compared with sham or no treatment (with/without MGX) (low certainty).
1 finding from 1 review
- Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction 2020 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedLow
IPL (with/without MGX) vs no treatment/sham
Meibomian gland orifice plugging, at 3 months of · people with meibomian gland dysfunction
It is very uncertain whether IPL (with/without MGX) changes meibomian gland orifice plugging, at 3 months of compared with sham or no treatment (with/without MGX) (very low certainty).
1 finding from 1 review
- Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction 2020 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedVery low
IPL (with/without MGX) vs no treatment/sham
Corneal sodium fluorescein staining, measured using a validated clinical scale, at 3 months of · people with meibomian gland dysfunction
It is very uncertain whether IPL (with/without MGX) changes corneal sodium fluorescein staining, measured using a validated… compared with sham or no treatment (with/without MGX) (very low certainty).
1 finding from 1 review
- Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction 2020 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedVery low